Ally Financial Inc. purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 6,000 shares of the company's stock, valued at approximately $2,339,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Nomura Asset Management Co. Ltd. lifted its holdings in shares of HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company's stock worth $29,990,000 after purchasing an additional 3,724 shares during the last quarter. Sunbelt Securities Inc. raised its stake in HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock valued at $2,954,000 after acquiring an additional 3,945 shares in the last quarter. Advisors Capital Management LLC grew its stake in shares of HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company's stock worth $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in shares of HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company's stock valued at $1,078,966,000 after purchasing an additional 245,887 shares in the last quarter. Finally, Liberty Wealth Management LLC bought a new position in HCA Healthcare in the 4th quarter valued at about $1,905,000. Institutional investors and hedge funds own 62.73% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on HCA shares. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research note on Monday, July 27th. Truist Financial decreased their price target on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. Royal Bank Of Canada reissued an "outperform" rating and issued a $435.00 price objective on shares of HCA Healthcare in a research note on Monday, July 27th. Sanford C. Bernstein reaffirmed a "market perform" rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. cut their price target on shares of HCA Healthcare from $490.00 to $425.00 and set a "neutral" rating for the company in a report on Thursday. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $462.64.
Get Our Latest Stock Report on HCA
HCA Healthcare Price Performance
HCA Healthcare stock opened at $429.08 on Monday. The company has a market cap of $92.90 billion, a P/E ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The firm's 50 day simple moving average is $397.16 and its 200-day simple moving average is $443.77.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company's revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.84 earnings per share. On average, analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is presently 10.45%.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.